The development of a schistosome vaccine

Parasitic Flatworms: Molecular Biology, Biochemistry, Immunology and Physiology

Volumn , Issue , 2006, Pages 303-326

  Wilson, R A ^a   Coulson, P S ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846428329     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (183)

1. Al-Sherbiny, M., Osman, A., Barakat, R., El Morshedy, H., Bergquist, R. and Olds, R. (2003) In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Tropica 88, 117-130.
2. Anderson, S., Coulson, P.S., Ljubojevic, S., Mountford, A.P. and Wilson, R.A. (1999) The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells. Immunology 96, 22-28.
3. Angeli, V., Faveeuw, C., Roye, O., Fontaine, J., Teissier, E., Capron, A., Wolowczuk, I., Capron, M. and Trottein, F. (2001) Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. The Journal of Experimental Medicine 193, 1135-1147.
4. Anonymous (1996) TDR News. The World Health Organization, number 50 June, Geneva, Switzerland.
5. Argiro, L., Henri, S., Dessein, H., Dessein, A.J. and Bourgois, A. (1999) Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocytemacrophage colony stimulating factor (GM-CSF) or IL-12 on alum. Vaccine 17, 13-18.
6. Argiro, L.L., Kohlstadt, S.S., Henri, S.S., Dessein, H.H., Matabiau, V.V., Paris, P.P., Bourgois, A.A. and Dessein, A.J. (2000) Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH. Vaccine 18, 2039-2048.
7. Arnon, R., Tarrab-Hazdai, R. and Steward, M. (2000) A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization. Immunology 101, 555-562.
8. Ashton, P.D., Curwen, R.S. and Wilson, R.A. (2001) Linking proteome and genome: how to identify parasite proteins. Trends in Parasitology 17, 198-202.
9. Auriault, C., Gras-Masse, H., Wolowczuk, I., Pierce, R.J., Balloul, J.M., Neyrinck, J.L., Drobecq, H., Tartar, A.and Capron, A. (1988) Analysis of T and B cell epitopes of the Schistosoma mansoni p28 antigen in the rat model by using synthetic peptides. The Journal of Immunology 141, 1687-1694.
10. Balloul, J.M., Pierce, R.J., Grzych, J.M. and Capron, A. (1985) In vitro synthesis of a 28 kilodalton antigen present on the surface of the schistosomulum of Schistosoma mansoni. Molecular and Biochemical Parasitology 17, 105-114.
11. Balloul, J.M., Grzych, J.M., Pierce, R.J. and Capron, A. (1987) A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. The Journal of Immunology 138, 3448-3453.
12. Balloul, J.M., Sondermeyer, P., Dreyer, D., Capron, M., Grzych, J.M., Pierce, R.J., Carvallo, D., Lecocq, J.P. and Capron, A. (1987b) Molecular cloning of a protective antigen of schistosomes. Nature 326, 149-153. and Capron, A. (1987) Molecular cloning of a protective antigen of schistosomes. Nature 326, 149-153.
13. Baras, B., Benoit, M.A., Dupre, L., Poulain-Godefroy, O., Schacht, A.M., Capron, A., Gillard, J. and Riveau, G. (1999) Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infection and Immunity 67, 2643-2648.
14. Baras, B., Benoit, M., Poulain-Godefroy, O., Schacht, A., Capron, A., Gillard, J. and Riveau, G. (2000) Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers. Vaccine 18, 1495-1505.
15. Beall, J.A. and Mitchell, G.F. (1986) Identification of a particular antigen from a parasite cDNA library using antibodies affinity purified from selected portions of Western blots. The Journal of Immunological Methods 86, 217-223.
16. Becker, M.M., Kalinna, B.H., Waine, G.J. and McManus, D.P. (1994) Gene cloning, overproduction and purification of a functionally active cytoplasmic fatty acid-binding protein (Sj-FABPc) from the human blood fluke Schistosoma japonicum. Gene 148, 321-325.
17. Ben-Yedidia, T., Tarrab-Hazdai, R., Schechtman, D. and Arnon, R. (1999) Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni. Infection and Immunity 67, 4360-4366.
18. Bickle, Q.D. and James, E.R. (1978) Resistance against Schistosoma mansoni induced by immunization of mice with cryopreserved schistosomula. Transactions of the Royal Society of Tropical Medicine and Hygiene 72, 677-678.
19. Bickle, Q.D., Andrews, B.J. and Taylor, M.G. (1986) Schistosoma mansoni: characterization of two protective monoclonal antibodies. Parasite Immunology 8, 95-107.
20. Bickle, Q.D., Bogh, H.O., Johansen, M.V. and Zhang, Y. (2001) Comparison of the vaccine efficacy of gamma-irradiated Schistosoma japonicum cercariae with the defined antigen Sj62(IrV-5) in pigs. Veterinary Parasitology 100, 51-62.
21. Boulanger, D., Reid, G.D., Sturrock, R.F., Wolowczuk, I., Balloul, J.M., Grezel, D., Pierce, R.J., Otieno, M.F., Guerret, S., Grimaud, J.A., et al. (1991) Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunology 13, 473-490.
22. Boulanger, D., Trottein, F., Mauny, F., Bremond, P., Couret, D., Pierce, R.J., Kadri, S., Godin, C., Sellin, E., Lecocq, J.P., Sellin, B. and Capron, A (1994) Vaccination of goats against the trematode Schistosoma bovis with a recombinant homologous schistosome-derived glutathione S-transferase. Parasite Immunology 16, 399-406.
23. Boulanger, D., Warter, A., Trottein, F., Mauny, F., Bremond, P., Audibert, F., Couret, D., Kadri, S., Godin, C., Sellin, E., Pierce, R.J., Lecocq, J.P., Sellin, B. and Capron, A. (1995) Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S. mansoni. Parasite Immunology 17, 361-369.
24. Boulanger, D., Schneider, D., Chippaux, J.P., Sellin, B. and Capron, A. (1999) Schistosoma bovis: vaccine effects of a recombinant homologous glutathione S-transferase in sheep. International Journal for Parasitology 29, 415-418.
25. Boulanger, D., Warter, A., Sellin, B., Lindner, V., Pierce, R.J., Chippaux, J.P. and Capron, A. (1999) Vaccine potential of a recombinant S-transferase cloned from Schistosoma haematobium in primates experimentally infected with an homologous challenge. Vaccine 17, 319-326.
26. Braschi, S., Curwen, R.S., Ashton, P.D., Verjouski-Almeida, S. and Wilson, R.A. (2005) The tegument surface membranes of the human blood fluke Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics (in press).
27. Bushara, H.O., Bashir, M.E., Malik, K.H., Mukhtar, M.M., Trottein, F., Capron, A. and Taylor, M.G. (1993) Suppression of Schistosoma bovis egg production in cattle by vaccination with either glutathione S-transferase or keyhole limpet haemocyanin. Parasite Immunology 15, 383-390.
28. Butterworth, A.E., Sturrock, R.F., Houba, V. and Rees, P.H. (1974) Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature 252, 503-505.
29. Butterworth, A.E., Taylor, D.W., Veith, M.C., Vadas, M.A., Dessein, A., Sturrock, R.F. and Wells, E. (1982) Studies on the mechanisms of immunity in human schistosomiasis. Immunological Reviews 61, 5-39.
30. Capron, A., Capron, M. and Riveau, G. (2002) Vaccine development against schistosomiasis from concepts to clinical trials. British Medical Bulletin 62, 139-148.
31. Charrier-Ferrara, S., Caillol, D. and Goudot-Crozel, V. (1992) Complete sequence of the Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase gene encoding a major surface antigen. Molecular and Biochemical Parasitology 56, 339-343.
32. Chen, H., Nara, T., Zeng, X., Satoh, M., Wu, G., Jiang, W., Yi, F., Kojima, S., Zhang, S. and Hirayama, K. (2000) Vaccination of domestic pig with recombinant paramyosin. Against Schistosoma japonicum in China. Vaccine 18, 2142-2146.
33. Chitsulo, L., Loverde, P. and Engels, D. (2004) Schistosomiasis. Nature Reviews in Microbiology 2, 12-13.
34. Chlichlia, K., Bahgat, M., Ruppel, A. and Schirrmacher, V. (2001) DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine 20, 439-447.
35. Cook, R.M., Carvalho-Queiroz, C., Wilding, G. and LoVerde, P.T. (2004) Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confer protection against the adult worm stage. Infection and Immunity 72, 6112-6124.
36. Coulson, P.S. (1997) The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Advances in Parasitology 39, 271-336.
37. Coulson, P.S., Smythies, L.E., Betts, C., Mabbott, N.A., Sternberg, J.M., Wei, X.G., Liew, F.Y. and Wilson, R.A. (1998) Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination. Immunology 93, 55-63.
38. Cox, F.E. (1990) Schistosomiasis. The mouse that wasn't immune. Nature 345, 18.
39. Crabtree, J.E. and Wilson, R.A. (1985) Schistosoma mansoni: an ultrastructural examination of skin migration in the hamster cheek pouch. Parasitology 91, 111-120.
40. Curwen, R.S. and Wilson, R.A. (2003) Invasion of skin by schistosome cercariae: some neglected facts. Trends in Parasitology 19, 63-66.
41. Curwen, R.S., Ashton, P.D., Johnston, D.A. and Wilson, R.A. (2004) The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Molecular and Biochemical Parasitology 138, 57-66.
42. Da'Dara, A.A., Skelly, P.J., Wang, M.M. and Harn, D.A. (2001) Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20, 359-369.
43. Da'Dara, A.A., Skelly, P.J., Walker, C.M. and Harn, D.A. (2003) A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunology 25, 429-437.
44. Dalton, J.P. and Strand, M. (1987) Schistosoma mansoni polypeptides immunogenic in mice vaccinated with radiation-attenuated cercariae. The Journal of Immunology 139, 2474-2481.
45. Damian, R.T., Roberts, M.L., Powell, M.R., Clark, J.D., Lewis, F.A. and Stirewalt, M.A. (1984) Schistosoma mansoni egg granuloma size reduction in challenged baboons after vaccination with irradiated cryopreserved schistosomula. Proceedings of the National Academy of Sciences USA 81, 3552-3556.
46. Dean, D.A., Bukowski, M.A. and Clark, S.S. (1981) Attempts to transfer the resistance of Schistosoma mansoni- infected and irradiated cercaria-immunized mice by means of parabiosis. American Journal of Tropical Medicine and Hygiene 30, 113-120.
47. Dessein, A., Samuelson, J.C., Butterworth, A.E., Hogan, M., Sherry, B.A., Vadas, M.A. and David, J.R. (1981) Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules. Parasitology 82, 357-374.
48. Dessein, A.J., Begley, M., Demeure, C., Caillol, D., Fueri, J., dos Reis, M.G., Andrade, Z.A., Prata, A. and Bina, J.C. (1988) Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37- kDa larval surface antigen. The Journal of Immunology 140, 2727-2736.
49. Dunne, D.W., Bickle, Q.D., Butterworth, A.E. and Richardson, B.A. (1987) The blocking of human antibodydependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula by monoclonal antibodies which cross-react with a polysaccharide-containing egg antigen. Parasitology 94, 269-280.
50. Dupre, L., Kremer, L., Wolowczuk, I., Riveau, G., Capron, A. and Locht, C. (2001) Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 19, 1373-1380.
51. Eberl, M., Langermans, J.A., Frost, P.A., Vervenne, R.A., van Dam, G.J., Deelder, A.M., Thomas, A.W., Coulson, P.S. and Wilson, R.A. (2001) Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infection and Immunity 69, 5352-5362.
52. Feng, Z., Li, Y., Qiu, Z., Xue, W., Guan, X. and Wu, G. (2000) Anti-fecundity immunity in mice immunized with anti-idiotypic monoclonal antibodyNP of Schistosoma japonicum. Chinese Medical Journal (Engl.) 113, 265-268.
53. Feng, Z., Qiu, Z., Li, Y., Zhu, C., Xue, W. and Guan, X. (2002) Protective immunity induced by the anti-idiotypic monoclonal antibody NP30 of Schistosoma japonicum. Chinese Medical Journal (Engl.) 115, 576-579.
54. Ferru, I., Georges, B., Bossus, M., Estaquier, J., Delacre, M., Harn, D.A., Tartar, A., Capron, A., Grassmasse, H. and Auriault, C. (1997) Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunology 19, 1-11.
55. Flanigan, T.P., King, C.H., Lett, R.R., Nanduri, J. and Mahmoud, A.A. (1989) Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin. The Journal of Clinical Investigation 83, 1010-1014.
56. Fulford, A.J., Butterworth, A.E., Sturrock, R.F. and Ouma, J.H. (1992) On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 105, 219-227.
57. Fusco, A.C., Salafsky, B. and Kevin, M.B. (1985) Schistosoma mansoni: eicosanoid production by cercariae. Experimental Parasitology 59, 44-50.
58. Gobert, G.N., Stenzel, D.J., Jones, M.K. and McManus, D.P. (1997) Immunolocalization of the fatty acidbinding protein Sj-FABPc within adult Schistosoma japonicum. Parasitology 115, 33-39.
59. Goudot-Crozel, V., Caillol, D., Djabali, M. and Dessein, A.J. (1989) The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3-dehydrogenase. Journal of Experimental Medicine 170, 2065-2080.
60. Grzych, J.M., Capron, M., Bazin, H. and Capron, A. (1982) In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. The Journal of Immunology 129, 2739-2743.
61. Grzych, J.M., Capron, M., Dissous, C. and Capron, A. (1984) Blocking activity of rat monoclonal antibodies in experimental schistosomiasis. The Journal of Immunology 133, 998-1004.
62. Grzych, J.M., Capron, M., Lambert, P.H., Dissous, C., Torres, S. and Capron, A. (1985) An anti-idiotype vaccine against experimental schistosomiasis. Nature 316, 74-76.
63. Hagan, P., Blumenthal, U.J., Dunn, D., Simpson, A.J. and Wilkins, H.A. (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349, 243-245.
64. Harn, D.A., Mitsuyama, M. and David, J.R. (1984) Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. The Journal of Experimental Medicine 159, 1371-1387.
65. Harn, D.A., Mitsuyama, M., Huguenel, E.D. and David, J.R. (1985) Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen, which may be blocked by host molecules on lung stage parasites. The Journal of Immunology 135, 2115-2120.
66. Harn, D.A., Gu, W., Oligino, L.D., Mitsuyama, M., Gebremichael, A. and Richter, D. (1992) A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triosephosphate isomerase. The Journal of Immunology 148, 562-567.
67. Harn, D.A., Reynolds, S.R., Chikunguwo, S.M., Furlong, S.T. and Dahl, C.E. (1995) Synthetic peptide vaccines for schistosomiasis. In: Powell, M.F. and Newman, M.J. (eds) Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York, pp. 891-905.
68. Harris, A.R., Russell, R.J. and Charters, A.D. (1984) A review of schistosomiasis in immigrants in Western Australia, demonstrating the unusual longevity of Schistosoma mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene 78, 385-388.
69. Harrison, R.A., Bickle, Q. and Doenhoff, M.J. (1982) Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. Evidence that the mechanisms, which mediate resistance during early patent infections, may lack immunological specificity. Parasitology 84, 93-110.
70. Harrop, R., Coulson, P.S. and Wilson, R.A. (1999) Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma mansoni. Parasitology 118, 583-594.
71. Hayunga, E.G. (1985) Attempted immunization of mice against S. mansoni by inoculation with purified glycoprotein antigens from adult worms. Proceedings of the Helminthological Society of Washington 52, 184-195.
72. Hazdai, R.T., Levi-Schaffer, F., Brenner, V., Horowitz, S., Eshhar, Z. and Arnon, R. (1985) Protective monoclonal antibody against Schistosoma mansoni: antigen isolation, characterization, and suitability for active immunization. The Journal of Immunology 135, 2772-2779.
73. Herve, M., Angeli, V., Pinzar, E., Wintjens, R., Faveeuw, C., Narumiya, S., Capron, A., Urade, Y., Capron, M., Riveau, G. and Trottein, F. (2003) Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. European Journal of Immunology 33, 2764-2772.
74. Hillyer, G.V. (1995) Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein. Memorias do Instituto Oswaldo Cruz 90, 249-253.
75. Hillyer, G.V., Garcia Rosa, M.I., Alicea, H. and Hernandez, A. (1988) Successful vaccination against murine Schistosoma mansoni infection with a purified 12 kD Fasciola hepatica cross-reactive antigen. American Journal of Tropical Medicine and Hygiene 38, 103-110.
76. Hockley, D.J. and McLaren, D.J. (1973) Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm. International Journal for Parasitology 3, 13-25.
77. Hoffman, S.L. (2000) Infectious disease. Research (genomics) is crucial to attacking malaria. Science 290, 1509.
78. Hoffman, S.L., Goh, L.M., Luke, T.C., Schneider, I., Le, T.P., Doolan, D.L., Sacci, J., de la Vega, P., Dowler, M., Paul, C., Gordon, D.M., Stoute, J.A., Church, L.W., Sedegah, M., Heppner, D.G., Ballou, W.R. and Richie, T.L. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. Journal of Infectious Diseases 185, 1155-1164.
79. Hoffmann, K.F., Johnston, D.A. and Dunne, D.W. (2002) Identification of Schistosoma mansoni genderassociated gene transcripts by cDNA microarray profiling. Genome Biology 3, research0041.1-0041.12.
80. Horowitz, S., Brenner, V. and Arnon, R. (1985) In vivo protection against S. mansoni infection by monoclonal antibodies. Immunology Letters 9, 69-73.
81. Hota-Mitchell, S., Siddiqui, A.A., Dekaban, G.A., Smith, J., Tognon, C. and Podesta, R.B. (1997) Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain. Vaccine 15, 1631-1640.
82. Hota-Mitchell, S., Clarke, M.W., Podesta, R.B. and Dekaban, G.A. (1999) Recombinant vaccinia viruses and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain used in a murine immunization- challenge model. Vaccine 17, 1338-1354.
83. James, S.L. (1985) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine is dependent on the method of antigen presentation. The Journal of Immunology 134, 1956-1960.
84. James, S.L. (1986) Activated macrophages as effector cells of protective immunity to schistosomiasis. Immunologic Research 5, 139-148.
85. James, S.L. (1987) Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. V. Effects of varying the immunization and infection schedule and site. Parasite Immunology 9, 531-541.
86. James, S.L. and DeBlois, L.A. (1986) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. The Journal of Immunology 136, 3864-3871.
87. James, S.L. and Pearce, E.J. (1988) The influence of adjuvant on induction of protective immunity by a nonliving vaccine against schistosomiasis. The Journal of Immunology 140, 2753-2759.
88. James, S.L., Pearce, E.J. and Sher, A. (1985) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts. The Journal of Immunology 134, 3432-3438.
89. Jankovic, D., Aslund, L., Oswald, I.P., Caspar, P., Champion, C., Pearce, E., Coligan, J.E., Strand, M., Sher, A.
90. James, S.L. (1996) Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. The Journal of Immunology 157, 806-814.
91. Kalinna, B.H., Becker, M.M. and McManus, D.P. (1997) Engineering and expression of a full-length cDNA encoding Schistosoma japonicum paramyosin. Purification of the recombinant protein and its recognition by infected patient sera. Acta Tropica 65, 111-115.
92. Kariuki, T.M., Farah, I.O., Yole, D.S., Mwenda, J.M., Van Dam, G.J., Deelder, A.M., Wilson, R.A. and Coulson, P.S. (2004) Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infection and Immunity 72, 5526-5529.
93. Khan, C.M., Villarreal-Ramos, B., Pierce, R.J., Demarco de Hormaeche, R., McNeill, H., Ali, T., Chatfield, S., Capron, A., Dougan, G. and Hormaeche, C.E. (1994) Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the p28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. The Journal of Immunology 153, 5634-5642.
94. Khan, C.M., Villarreal-Ramos, B., Pierce, R.J., Riveau, G., Demarco de Hormaeche, R., McNeill, H., Ali, T., Fairweather, N., Chatfield, S., Capron, A., Dougan, G. and Hormaeche, C.E. (1994) Construction, expression, and immunogenicity of the Schistosoma mansoni p28 glutathione S-transferase as a genetic fusion to tetanus toxin C in a live aro attenuated vaccine strain of Salmonella. Proceedings of the National Academy of Sciences USA 91, 11261-11265.
95. Kremer, L., Riveau, G., Baulard, A., Capron, A. and Locht, C. (1996) Neutralizing antibody responses elicited in mice immunized with recombinant Bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase. The Journal of Immunology 156, 4309-4317.
96. Kresina, T.F. and Olds, G.R. (1989) Antiidiotypic antibody vaccine in murine schistosomiasis mansoni comprising the internal image of antigen. The Journal of Clinical Investigation 83, 912-920.
97. Lanar, D.E., Pearce, E.J., James, S.L. and Sher, A. (1986) Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice. Science 234, 593-596.
98. Lane, A., Boulanger, D., Riveau, G., Capron, A. and Wilson, R.A. (1998) Murine immune responses to Schistosoma haematobium and the vaccine candidate rSh28GST. Parasite Immunology 20, 359-367.
99. Lebens, M., Sun, J.B., Sadeghi, H., Backstrom, M., Olsson, I., Mielcarek, N., Li, B.L., Capron, A., Czerkinsky, C. and Holmgren, J. (2003) A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection. Vaccine 21, 514-520.
100. Lewis, F.A., Stirewalt, M. and Leef, J.L. (1984) Schistosoma mansoni: radiation dose and morphologic integrity of schistosomules as factors for an effective cryopreserved live vaccine. American Journal of Tropical Medicine and Hygiene 33, 125-131.
101. Liu, S.X., Song, G.C., Xu, Y.X., Yang, W. and McManus, D.P. (1995) Anti-fecundity immunity induced in pigs vaccinated with recombinant Schistosoma japonicum 26 kDa glutathione-S-transferase. Parasite Immunol 17, 355-340.
102. Luke, T.C. and Hoffman, S.L. (2003) Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. Journal of Experimental Biology 206, 3803-3808.
103. Maddison, S.E., Slemenda, S.B., Chandler, F.W. and Kagan, I.G. (1978) Studies on putative adult wormderived vaccines and adjuvants for protection against Schistosoma mansoni infection in mice. Journal of Parasitology 64, 986-993.
104. Mangold, B.L. and Dean, D.A. (1986) Passive transfer with serum and IgG antibodies of irradiated cercariainduced resistance against Schistosoma mansoni in mice. The Journal of Immunology 136, 2644-2648.
105. McKerrow, J.H., Pino-Heiss, S., Lindquist, R. and Werb, Z. (1985) Purification and characterization of an elastinolytic proteinase secreted by cercariae of Schistosoma mansoni. The Journal of Biological Chemistry 260, 3703-3707.
106. McLaren, D.J., Ramalho-Pinto, F.J. and Smithers, S.R. (1978) Ultrastructural evidence for complement and antibody-dependent damage to schistosomula of Schistosoma mansoni by rat eosinophils in vitro. Parasitology 77, 313-324.
107. McManus, D.P., Liu, S., Song, G., Xu, Y. and Wong, J.M. (1998) The vaccine efficacy of native paramyosin (Sj- 97) against Chinese Schistosoma japonicum. International Journal for Parasitology 28, 1739-1742.
108. McManus, D.P., Wong, J.Y., Zhou, J., Cai, C., Zeng, Q., Smyth, D., Li, Y., Kalinna, B.H., Duke, M.J. and Yi, X. (2001) Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes. Vaccine 20, 870-878.
109. Mendlovic, F., Tarrab-Hazdai, R., Puri, J. and Arnon, R. (1989) Genetic control of immune response to a purified Schistosoma mansoni antigen. I. Effect of MHC class II antigens on the cellular, humoral and protective responses. Parasite Immunology 11, 667-682.
110. Mielcarek, N., Cornette, J., Schacht, A.M., Pierce, R.J., Locht, C., Capron, A. and Riveau, G. (1997) Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen. Infection and Immunity 65, 544-550.
111. Mielcarek, N., Riveau, G., Remoue, F., Antoine, R., Capron, A. and Locht, C. (1998) Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nature Biotechnology 16, 454-457.
112. Mitchell, G.F., Cruise, K.M., Garcia, E.G. and Tiu, W.U. (1984) Anti-worm antibody specificities in 129/j mice resistant to infection with Schistosoma japonicum. Journal of Parasitology 70, 983-985.
113. Mitchell, G.F., Garcia, E.G., Davern, K.M., Tiu, W.U. and Smith, D.B. (1988) Sensitization against the parasite antigen Sj26 is not sufficient for consistent expression of resistance to Schistosoma japonicum in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 885-889.
114. Mohamed, M.M., Shalaby, K.A., LoVerde, P.T. and Karim, A.M. (1998) Characterization of Sm20.8, a member of a family of schistosome tegumental antigens. Molecular and Biochemical Parasitology 96, 15-25.
115. Moser, D., Tendler, M., Griffiths, G. and Klinkert, M.Q. (1991) A 14-kda Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. The Journal of Biological Chemistry 266, 8447-8454.
116. Mountford, A.P., Anderson, S. and Wilson, R.A. (1996) Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. The Journal of Immunology 156, 4739-4745.
117. Murrell, K.D., Dean, D.A. and Stafford, E.E. (1975) Resistance to infection with Schistosoma mansoni after immunization with worm extracts or live cercariae: role of cytotoxic antibody in mice and guinea pigs. The American Journal of Tropical Medicine and Hygiene 24, 955-962.
118. Murrell, K.D., Clark, S.S., Dean, D.A. and Vannier, W.E. (1979) Schistosoma mansoni: immunization of cynomolgus monkeys by injection of irradiated schistosomula. Experimental Parasitology 48, 415-420.
119. Newport, G.R., McKerrow, J.H., Hedstrom, R., Petitt, M., McGarrigle, L., Barr, P.J. and Agabian, N. (1988) Cloning of the proteinase that facilitates infection by schistosome parasites. The Journal of Biological Chemistry 263, 13179-13184.
120. Omer Ali, P., Smithers, S.R., Bickle, Q., Phillips, S.M., Harn, D. and Simpson, A.J. (1988) Analysis of the anti- Schistosoma mansoni surface antibody response during murine infection and its potential contribution to protective immunity. The Journal of Immunology 140, 3273-3279.
121. Pearce, E.J., James, S.L., Dalton, J., Barrall, A., Ramos, C., Strand, M. and Sher, A. (1986) Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. The Journal of Immunology 137, 3593-3600.
122. Pearce, E.J., James, S.L., Hieny, S., Lanar, D.E. and Sher, A. (1988) Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proceedings of the National Academy of Sciences USA 85, 5678-5682.
123. Ramalho-Pinto, F.J. McLaren, D.J. and Smithers, S.R. (1978) Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro. The Journal of Experimental Medicine 147, 147-156.
124. Ramirez, B.L., Kurtis, J.D., Wiest, P.M., Arias, P., Aligui, F., Acosta, L., Peters, P. and Olds, G.R. (1996) Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunology 18, 49-52.
125. Rao, K.V. and Ramaswamy, K. (2000) Cloning and expression of a gene encoding Sm16, an anti-inflammatory protein from Schistosoma mansoni. Molecular and Biochemical Parasitology 108, 101-108.
126. Rappuoli, R. and Covacci, A. (2003) Reverse vaccinology and genomics. Science 302, 602.
127. Reynolds, S.R., Shoemaker, C.B. and Harn, D.A. (1992) T and B cell epitope mapping of Sm23, an integral membrane protein of Schistosoma mansoni. The Journal of Immunology 149, 3995-4001.
128. Reynolds, S.R., Dahl, C.E. and Harn, D.A. (1994) T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. The Journal of Immunology 152, 193-200.
129. Ribeiro de Jesus, A., Araujo, I., Bacellar, O., Magalhaes, A., Pearce, E., Harn, D., Strand, M. and Carvalho, E.M. (2000) Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infection and Immunity 68, 2797-2803.
130. Roberts, S.M., Boot, C. and Wilson, R.A. (1988) Antibody responses of rodents to a tegument membrane preparation from adult Schistosoma mansoni. Parasitology 97, 425-435.
131. Sadun, E.H. and Lin, S.S. (1959) Studies on the host-parasite relationships to Schistosoma japonicum. IV. Resistance acquired by infection, by vaccination and by the injection of immune serum, in monkeys, rabbits and mice. Journal of Parasitology 45, 543-548.
132. Santiago, M.L., Hafalla, J.C., Kurtis, J.D., Aligui, G.L., Wiest, P.M., Olveda, R.M., Olds, G.R., Dunne, D.W.and Ramirez, B.L. (1998) Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides. International Archives of Allergy and Immunology 117, 94-104.
133. Scott, J.C. and McManus, D.P. (2000) Molecular cloning and enzymatic expression of the 28-kDa glutathione S-transferase of Schistosoma japonicum: evidence for sequence variation but lack of consistent vaccine efficacy in the murine host. Parasitology International 49, 289-300.
134. Scott, J.C., Kennedy, M.W. and McManus, D.P. (2000) Molecular and immunological characterisation of a polymorphic cytosolic fatty acid binding protein from the human blood fluke Schistosoma japonicum. Biochimica et Biophysica Acta 1517, 53-62.
135. Sher, A., Pearce, E., Hieny, S. and James, S. (1986) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. IV. Fractionation and antigenic properties of a soluble adult worm immunoprophylactic activity. The Journal of Immunology 136, 3878-3883.
136. Shi, F., Zhang, Y., Ye, P., Lin, J., Cai, Y., Shen, W., Bickle, Q.D. and Taylor, M.G. (2001) Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China. Vaccine 20, 462-467.
137. Shi, F., Zhang, Y., Lin, J., Zuo, X., Shen, W., Cai, Y., Ye, P., Bickle, Q.D. and Taylor, M.G. (2002) Field testing of Schistosoma japonicum DNA vaccines in cattle in China. Vaccine 20, 3629-3631.
138. Siddiqui, A.A., Phillips, T., Charest, H., Podesta, R.B., Quinlin, M.L., Pinkston, J.R., Lloyd, J.D., Paz, M., Villalovos, R.M. and Pompa, J. (2003) Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte- macrophage colony-stimulating factor and interleukin-4. Infection and Immunity 71, 3844-3851.
139. Siddiqui, A.A., Phillips, T., Charest, H., Podesta, R.B., Quinlin, M.L., Pinkston, J.R., Lloyd, J.D., Pompa, J., Villalovos, R.M. and Paz, M. (2003) Enhancement of Sm-p80 (large subunit of calpain) inducedprotective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin- 12 in a DNA vaccine formulation. Vaccine 21, 2882-2889.
140. Skelly, P.J. (2004) Intravascular schistosomes and complement. Trends in Parasitology 20, 370-374.
141. Skelly, P.J. and Shoemaker, C.B. (1996) Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni. Proceedings of the National Academy of Sciences USA 93, 3642-3646.
142. Smith, D.B., Davern, K.M., Board, P.G., Tiu, W.U., Garcia, E.G. and Mitchell, G.F. (1986) Mr 26,000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/j mice is a parasite glutathione S-transferase. Proceedings of the National Academy of Sciences USA 83, 8703-8707.
143. Smithers, S.R. (1987) Vaccination against schistosomes and other systemic helminths. International Journal for Parasitology 17, 31-42.
144. Smithers, S.R., Hackett, F., Ali, P.O. and Simpson, A.J. (1989) Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes. Parasite Immunology 11, 301-318.
145. Smythies, L.E., Coulson, P.S. and Wilson, R.A. (1992) Monoclonal antibody to Interferon-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. The Journal of Immunology 149, 3654-3658.
146. Soisson, L.M., Masterson, C.P., Tom, T.D., McNally, M.T., Lowell, G.H. and Strand, M. (1992) Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. The Journal of Immunology 149, 3612-3620.
147. Soisson, L.A., Reid, G.D., Farah, I.O., Nyindo, M. and Strand, M. (1993) Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody- dependent. The Journal of Immunology 151, 4782-4789.
148. Street, M., Coulson, P.S., Sadler, C., Warnock, L.J., McLaughlin, D., Bluethmann, H. and Wilson, R.A. (1999) TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. The Journal of Immunology 163, 4489-4494.
149. Sun, J.B., Mielcarek, N., Lakew, M., Grzych, J.M., Capron, A., Holmgren, J. and Czerkinsky, C. (1999) Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. The Journal of Immunology 163, 1045-1052.
150. Tarrab-Hazdai, R., Schechtman, D. and Arnon, R. (1998) Synthesis and characterization of a protective peptide- based vaccine against Schistosoma mansoni. Infection and Immunity 66, 4526-4530.
151. Tarrab-Hazdai, R., Schechtman, D., Lowell, G., Pirak, E. and Arnon, R. (1999) Proteosome delivery of a protective 9b-antigen against Schistosoma mansoni. International Journal of Immunopharmacology 21, 205-218.
152. Taylor, J.B., Vidal, A., Torpier, G., Meyer, D.J., Roitsch, C., Balloul, J.M., Southan, C., Sondermeyer, P., Pemble, S., Lecocq, J.P., Capron, A. and Ketterer, B. (1988) The glutathione transferase activity and tissue distribution of a cloned mr28k protective antigen of Schistosoma mansoni. EMBO Journal 7, 465-472.
153. Taylor, M.G., Huggins, M.C., Shi, F., Lin, J., Tian, E., Ye, P., Shen, W., Qian, C.G., Lin, B.F. and Bickle, Q.D. (1998) Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine 16, 1290-1298.
154. Tendler, M., Pinto, R.M., Oliveira Lima, A., Gebara, G. and Katz, N. (1986) Schistosoma mansoni: vaccination with adult worm antigens. International Journal for Parasitology 16, 347-352.
155. Tendler, M., Pinto, R.M., Lima Ade, O., Savino, W. and Katz, N. (1991) Vaccination in murine schistosomiasis with adult worm-derived antigens: variables influencing protection in outbred mice. International Journal for Parasitology 21, 299-306.
156. Tendler, M., Brito, C.A., Vilar, M.M., Serra-Freire, N., Diogo, C.M., Almeida, M.S., Delbem, A.C., Da Silva, J.F., Savino, W., Garratt, R.C., Katz, N. and Simpson, A.S. (1996) A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proceedings of the National Academy of Sciences USA 93, 269-273.
157. Tiu, W.U., Ehl, A., Walker, J.C., Garcia, E.G., Smith, D.B. and Mitchell, G.F. (1986) Resistance of 129/j mice to Schistosoma mansoni infection. Australian Journal of Experimental Biology and Medical Science 64, 345-349.
158. van der Werf, M.J., de Vlas, S.J., Brooker, S., Looman, C.W., Nagelkerke, N.J., Habbema, J.D. and Engels, D. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Tropica 86, 125-139.
159. Verity, C.K., McManus, D.P. and Brindley, P.J. (2001) Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum. Parasite Immunology 23, 153-162.
160. Verjovski-Almeida, S., DeMarco, R., Martins, E.A., Guimaraes, P.E., Ojopi, E.P., Paquola, A.C., Piazza, J.P., Nishiyama, M.Y. Jr, Kitajima, J.P., Adamson, R.E., Ashton, P.D., Bonaldo, M.F., Coulson, P.S., Dillon, G.P., Farias, L.P., Gregorio, S.P., Ho, P.L., Leite, R.A., Malaquias, L.C., Marques, R.C., Miyasato, P.A., Nascimento, A.L., Ohlweiler, F.P., Reis, E.M., Ribeiro, M.A., Sa, R.G., Stukart, G.C., Soares, M.B., Gargioni, C., Kawano, T., Rodrigues, V., Madeira, A.M., Wilson, R.A., Menck, C.F., Setubal, J.C., Leite, L.C. and Dias-Neto, E. (2003) Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nature Genetics 35, 148-157.
161. Verwaerde, C., Joseph, M., Capron, M., Pierce, R.J., Damonneville, M., Velge, F., Auriault, C. and Capron, A. (1987) Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. The Journal of Immunology 138, 4441-4446.
162. Waine, G.J., Alarcon, J.B., Qiu, C. and McManus, D.P. (1999) Genetic immunization of mice with DNA encoding the 23 kDa transmembrane surface protein of Schistosoma japonicum (Sj23) induces antigenspecific immunoglobulin G antibodies. Parasite Immunology 21, 377-381.
163. Wheater, P.R. and Wilson, R.A. (1979) Schistosoma mansoni: a histological study of migration in the laboratory mouse. Parasitology 79, 49-62.
164. Wilson, R.A. and Barnes, P.E. (1977) The formation and turnover of the membranocalyx on the tegument of Schistosoma mansoni. Parasitology 74, 61-71.
165. Wilson, R.A. and Coulson, P.S. (1998) Why don't we have a schistosomiasis vaccine? Parasitology Today 14, 97-99.
166. Wilson, R.A. and Coulson, P.S. (1999) Strategies for a schistosome vaccine: can we manipulate the immune response effectively? Microbes and Infection 1, 535-543.
167. Wilson, R.A., Coulson, P.S. and McHugh, S.M. (1983) A significant part of the 'concomitant immunity' of mice to Schistosoma mansoni is the consequence of a leaky hepatic portal system, not immune killing. Parasite Immunology 5, 595-601.
168. Wilson, R.A., Coulson, P.S. and Mountford, A.P. (1999) Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice? Immunological Letters 65, 117-123.
169. Wolowczuk, I., Auriault, C., Bossus, M., Boulanger, D., Gras-Masse, H., Mazingue, C., Pierce, R.J., Grezel, D., Reid, G.D. and Tartar, A. (1991) Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization. The Journal of Immunology 146, 1987-1995.
170. Wynn, T.A., Jankovic, D., Hieny, S., Cheever, A.W., Sher, A. (1995) IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. The Journal of Immunology 154, 4701-4709.
171. Xu, S., Shi, F. and Wu, H. (1991) Schistosoma japonicum: some parameters affecting the development of protective immunity induced by a cryopreserved, irradiated schistosomula vaccine in guinea-pigs. Parasitology 102, 45-47.
172. Xu, C.B., Verwaerde, C., Gras-Masse, H., Fontaine, J., Bossus, M., Trottein, F., Wolowczuk, I., Tartar, A. and Capron, A. (1993) Schistosoma mansoni 28-kDa glutathione S-transferase and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domains. The Journal of Immunology 150, 940-949.
173. Xu, S., Shi, F., Shen, W., Lin, J., Wang, Y., Ye, P., Tian, E., Qian, C., Lin, B., Shi, Y. and Zhang, Z. (1995) Vaccination of sheep against Schistosoma japonicum with either glutathione S-transferase, keyhole limpet haemocyanin or the freeze/thaw schistosomula/BCG vaccine. Veterinary Parasitology 58, 301-312.
174. Yang, W., Jackson, D.C., Zeng, Q. and McManus, D.P. (2000) Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice. Vaccine 19, 103-113.
175. Yi, X.Y., Omer-Ali, P., Kelly, C., Simpson, A.J. and Smithers, S.R. (1986) IgM antibodies recognizing carbohydrate epitopes shared between schistosomula and miracidia of Schistosoma mansoni that block in vitro killing. The Journal of Immunology 137, 3946-3954.
176. Yole, D.S., Pemberton, R., Reid, G.D. and Wilson, R.A. (1996) Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine. Parasitology 112, 37-46.
177. Zhang, Y., Taylor, M.G. and Bickle, Q.D. (1998) Schistosoma japonicum myosin: cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5. Parasite Immunology 20, 583-594.
178. Zhang, Y.Y., Taylor, M.G., Gregoriadis, G., McCrossan, M.V. and Bickle, Q.D. (2000) Immunogenicity of plasmid DNA encoding the 62 kDa fragment of Schistosoma japonicum myosin. Vaccine 18, 2102-2109.
179. Zhang, Y., Taylor, M.G., Johansen, M.V. and Bickle, Q.D. (2001a) Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine 20, 724-730.
180. Zhang, R., Yoshida, A., Kumagai, T., Kawaguchi, H., Maruyama, H., Suzuki, T., Itoh, M., El-Malky, M. and Ohta, N. (2001b) Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum. Infection and Immunity 69, 386-391.
181. Zhou, S., Liu, S., Song, G., Xu, Y. and Sun, W. (2000) Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. Vaccine 18, 3196-3204.
182. Zhu, Y., Si, J., Ham, D.A., Yu, C., He, W., Hua, W., Yin, X., Liang, Y., Xu, M. and Xu, R. (2002) The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase. Southeast Asian Journal of Tropical Medicine and Public Health 33, 207-213.
183. Zhu, Y., Ren, J., Harn, D.A., Si, J., Yu, C., Ming, X. and Liang, Y. (2003) Protective immunity induced with 23 kDa membrane protein DNA vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice. Southeast Asian Journal of Tropical Medicine and Public Health 34, 697-701.